AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|AAPL308.06+13.68 (+4.65%) ▲|ABBV260.28+9.22 (+3.67%) ▲|ABT95.23+3.05 (+3.31%) ▲|ACN137.34+6.21 (+4.74%) ▲|ADBE219.67+8.69 (+4.12%) ▲|AMAT596.44-54.48 (-8.37%) ▼|AMD513.02-27.87 (-5.15%) ▼|AMGN373.03+11.70 (+3.24%) ▲|AMT165.72-0.36 (-0.22%) ▼|AMZN243.42+1.72 (+0.71%) ▲|AVGO360.59-8.76 (-2.37%) ▼|AXP351.20+4.15 (+1.20%) ▲|BA225.98+7.40 (+3.38%) ▲|BAC58.62+0.26 (+0.45%) ▲|BKNG184.56+1.92 (+1.05%) ▲|BLK992.05+11.67 (+1.19%) ▲|BMY57.97+2.16 (+3.87%) ▲|BNY146.19+0.17 (+0.12%) ▲|BRK-B506.38+6.64 (+1.33%) ▲|C139.65-0.48 (-0.34%) ▼|CAT963.39-28.02 (-2.83%) ▼|CL95.20+2.44 (+2.63%) ▲|CMCSA23.75+0.02 (+0.06%) ▲|COF204.38-0.44 (-0.21%) ▼|COP104.26+1.04 (+1.01%) ▲|COST951.40+26.73 (+2.89%) ▲|CRM165.36+2.13 (+1.30%) ▲|CSCO112.72-4.29 (-3.67%) ▼|CVS104.70-0.12 (-0.11%) ▼|CVX168.74+3.05 (+1.84%) ▲|DE620.75-6.88 (-1.10%) ▼|DHR197.24+3.52 (+1.82%) ▲|DIS99.28+3.57 (+3.73%) ▲|DUK129.46+3.69 (+2.93%) ▲|EMR138.93-0.60 (-0.43%) ▼|FDX313.07-0.82 (-0.26%) ▼|GD372.16+10.89 (+3.01%) ▲|GE376.93+1.99 (+0.53%) ▲|GEV1,109.39-24.96 (-2.20%) ▼|GILD131.18+5.21 (+4.14%) ▲|GM75.74+0.22 (+0.29%) ▲|GOOG356.40-1.49 (-0.42%) ▼|GOOGL360.23-0.98 (-0.27%) ▼|GS1,020.83+1.22 (+0.12%) ▲|HD357.29+6.45 (+1.84%) ▲|HON229.59+7.84 (+3.54%) ▲|IBM288.58+2.33 (+0.81%) ▲|INTC119.07-7.95 (-6.26%) ▼|INTU274.74+7.66 (+2.87%) ▲|ISRG425.32+22.94 (+5.70%) ▲|JNJ261.96+7.98 (+3.14%) ▲|JPM333.40-0.68 (-0.20%) ▼|KO83.75+2.46 (+3.02%) ▲|LIN545.51+11.96 (+2.24%) ▲|LLY1,203.65+11.91 (+1.00%) ▲|LMT544.69+22.87 (+4.38%) ▲|LOW226.79+4.87 (+2.19%) ▲|LRCX348.45-42.82 (-10.94%) ▼|MA538.21+15.77 (+3.02%) ▲|MCD280.20+10.77 (+4.00%) ▲|MDLZ60.92+1.57 (+2.65%) ▲|MDT83.16+3.96 (+5.00%) ▲|META584.25-28.66 (-4.68%) ▼|MMM160.71+0.75 (+0.47%) ▲|MO72.64+1.10 (+1.54%) ▲|MRK128.98+3.61 (+2.88%) ▲|MS214.00+2.14 (+1.01%) ▲|MSFT390.56+6.28 (+1.63%) ▲|MU963.56-68.72 (-6.66%) ▼|NEE88.14+1.77 (+2.05%) ▲|NFLX77.79+3.60 (+4.85%) ▲|NKE44.05+0.99 (+2.30%) ▲|NOW105.65-0.15 (-0.14%) ▼|NVDA194.53-3.05 (-1.54%) ▼|ORCL140.17-2.34 (-1.64%) ▼|PEP144.21+3.05 (+2.16%) ▲|PFE24.31+0.43 (+1.78%) ▲|PG150.88+3.45 (+2.34%) ▲|PLTR129.85+4.12 (+3.28%) ▲|PM182.64+4.95 (+2.79%) ▲|QCOM175.15-6.77 (-3.72%) ▼|RTX199.15+7.37 (+3.84%) ▲|SBUX104.31+0.92 (+0.89%) ▲|SCHW96.96+1.18 (+1.23%) ▲|SO97.81+2.69 (+2.83%) ▲|SPG225.49+2.49 (+1.11%) ▲|T20.55+0.07 (+0.34%) ▲|TMO520.99+7.66 (+1.49%) ▲|TMUS177.55+4.49 (+2.59%) ▲|TSLA392.94-32.36 (-7.61%) ▼|TXN291.69-6.72 (-2.25%) ▼|UBER74.40+1.74 (+2.39%) ▲|UNH423.95-2.60 (-0.61%) ▼|UNP281.85+4.12 (+1.48%) ▲|UPS110.39+0.85 (+0.78%) ▲|USB61.56-0.40 (-0.65%) ▼|V360.35+9.27 (+2.64%) ▲|VZ42.56+0.57 (+1.36%) ▲|WFC85.49-0.45 (-0.52%) ▼|WMT112.01+3.19 (+2.93%) ▲|XOM136.75+0.47 (+0.34%) ▲|
38.5 C
New York
Thursday, July 2, 2026

Tag: stock

MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Merck (MRK) To Contact Him Directly To Discuss Their Options

CENTENE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Centene Corporation (CNC) To Contact Him Directly To Discuss Their Options

FORTREA ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Fortrea Holdings (FTRE) to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fortrea Holdings (FTRE) To Contact Him Directly To Discuss Their Options

UROGEN ALERT: Bragar Eagel & Squire, P.C. Urges Investors in UroGen Pharma (URGN) to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UroGen Pharma (URGN) To Contact Him Directly To Discuss Their Options

RED CAT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Red Red Cat Holdings, Inc. Investors of July 22nd Deadline and Urges Them to...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Red Cat (RCAT) To Contact Him Directly To Discuss Their Options

ORGANON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Organon (OGN) To Contact Him Directly To Discuss Their Options

FTRE SECURITIES FRAUD: Fortrea Holdings Inc. (NASDAQ:FTRE) 25% Stock Drop Triggers Class Action Lawsuit – Contact BFA Law by August 1 Legal Deadline

Fortrea Holdings Inc. investors that lost money are notified to contact BFA Law before the August 1, 2025 securities fraud class action deadline.

TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, July 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class...

INVESTOR DEADLINE TUESDAY: Red Cat Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – RCAT

SAN DIEGO, July 18, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ:...

NEOG INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Neogen Corporation Investors with Substantial Losses Have Opportunity to Lead the Neogen Class...

SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Neogen Corporation (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”), have until September 16, 2025 to seek appointment as lead plaintiff of the Neogen class action lawsuit. Captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, No. 25-cv-00802 (W.D. Mich.), the Neogen class action lawsuit charges Neogen and certain of Neogen’s top executives with violations of the Securities Exchange Act of 1934.

Purpose Investments Inc. Announces July 2025 Distributions

TORONTO, July 18, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of July 2025 for its open-end exchange traded funds and closed-end funds (“the Funds”).

Portland General Electric declares dividend

PORTLAND, Ore., July 18, 2025 /PRNewswire/ -- On July 18, 2025, the board of directors of Portland General Electric Company (NYSE: POR) declared a...

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2025.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on July 17, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 138,190 shares of Iovance’s common stock to 20 new, non-executive employees.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsStock